Skip to main content
News Icon

News categories: Honors & Funding

Funding success for international Research Training Group

Joint project by Universities of Bonn and Melbourne extended until 2025

Launched in 2016, the international Research Training Group of the Universities of Bonn and Melbourne will now continue to receive funding until 2025.

This was confirmed by the German Research Foundation (DFG). The joint project facilitates the training of young researchers in an excellent academic environment at two globally distinguished research locations. The Research Training Group examines the role of certain immune cells in infections, tumor diseases, autoimmunity and vaccinations. The international Research Training Group allows doctoral students to establish an international network early on. The doctoral students are part of a structured program in which they are mentored by two senior researchers in Bonn and Melbourne. Of an average of three years of doctoral studies, the doctoral students spend one year at the partner university. Graduates are awarded a joint PhD of the Universities of Bonn and Melbourne.

"We are very happy that we can continue our successful cooperation. With this extension, the DFG is honoring the added value of international partnerships and the performance of our doctoral students. The entire team is very proud of this success," says Prof. Dr. Christian Kurts, Leibniz laureate and speaker of the Research Training Group in Bonn.

Obtaining a doctorate at the only German immunological Cluster of Excellence ImmunoSensation2 can be even more attractive for young researchers when they are given the opportunity to conduct one year of their research at one of Australia's leading universities. This is exactly what the German-Australian Research Training Group "Bonn & Melbourne Research and Graduate School Immunosciences" (ITRG 2168) has been offering since funding was confirmed by the DFG in April 2016.

Contact

Prof. Dr. Christian Kurts

Phone: +49 228 287-11050

Email: iei@uni-bonn.de

Related news

Prof. Dr. Frank G. Holz – Director of the Department of Ophthalmology at the University Hospital Bonn (UKB) and Professor at the University of Bonn.

News categories: Honors & Funding

Frank Holz Nominated for the Science Breakthrough of the Year 2026

A remarkable achievement for the Faculty of Medicine at the University of Bonn: Prof. Dr. Frank G. Holz, Director of the Department of Ophthalmology at the UKB and Professor at the University of Bonn, has been shortlisted for the Falling Walls Science Breakthrough of the Year 2026 in the Life Sciences category. His project is now among the 30 most outstanding scientific innovations worldwide in this category, recognized by the prestigious Falling Walls Science Summit. Being shortlisted alone represents a significant international distinction.
View entry
Prof. Dr. Elvira Mass (left) and Prof. Dr. Tatjana Tchumatchenko (right)

News categories: Honors & Funding

Hunting for New Angles

New research questions often arise where different methods, mindsets and subject-specific cultures meet, and it is these kinds of encounter that Professor Elvira Mass and Professor Tatjana Tchumatchenko want to make happen in a targeted way in future. The two researchers have been picked as Henriette Herz Scouts by the Alexander von Humboldt Foundation.
View entry
Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry

Back to the news overview